CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q3 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,890,299 | -30.5% | 63,677 | -14.0% | 0.01% | -23.1% |
| Q2 2023 | $4,156,549 | +98.1% | 74,039 | +59.6% | 0.01% | +62.5% |
| Q1 2023 | $2,098,536 | +12.5% | 46,397 | +1.1% | 0.01% | +100.0% |
| Q4 2022 | $1,865,998 | +317.4% | 45,904 | +570.5% | 0.00% | +300.0% |
| Q3 2022 | $447,000 | -94.6% | 6,846 | -95.0% | 0.00% | -92.3% |
| Q2 2022 | $8,249,000 | -41.7% | 135,747 | -39.8% | 0.01% | -7.1% |
| Q1 2022 | $14,156,000 | -61.0% | 225,519 | -52.9% | 0.01% | -51.7% |
| Q4 2021 | $36,283,000 | +11.1% | 478,797 | +64.1% | 0.03% | -17.1% |
| Q3 2021 | $32,665,000 | -49.5% | 291,836 | -27.0% | 0.04% | -55.1% |
| Q2 2021 | $64,715,000 | +40.9% | 399,747 | +6.1% | 0.08% | +14.7% |
| Q1 2021 | $45,925,000 | +343.5% | 376,894 | +457.2% | 0.07% | +277.8% |
| Q4 2020 | $10,356,000 | +15356.7% | 67,640 | +2783.2% | 0.02% | +1700.0% |
| Q4 2018 | $67,000 | -95.9% | 2,346 | -93.7% | 0.00% | -92.3% |
| Q3 2018 | $1,644,000 | +234.8% | 37,074 | +343.4% | 0.01% | +225.0% |
| Q2 2018 | $491,000 | -24.3% | 8,361 | -41.1% | 0.00% | -42.9% |
| Q1 2018 | $649,000 | +2063.3% | 14,193 | +1025.5% | 0.01% | – |
| Q4 2017 | $30,000 | – | 1,261 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |